- UroToday Home
- Recent Abstracts
- Urologic Oncology
Prostate Cancer
Molecular Hallmarks of Prostate-specific Membrane Antigen in Treatment-naïve Prostate Cancer.
September 19, 2024
Convergent alterations in the tumor microenvironment of MYC-driven human and murine prostate cancer.
September 19, 2024
Metastatic Hormone-Sensitive Prostate Cancer and Combination Treatment Outcomes: A Review.
September 18, 2024
Histopathology-validated gross tumor volume delineations of intraprostatic lesions using PSMA-positron emission tomography/multiparametric magnetic resonance imaging.
September 18, 2024
Trifecta Outcomes After Use of 3-Dimensional Digital Models for Planning of Robotic Prostatectomy: A Secondary Analysis of a Randomized Clinical Trial.
September 18, 2024
Evolving Paradigms in Prostate Cancer: The Integral Role of PSMA PET/CT in Primary Staging and Therapeutic Decision-Making.
September 18, 2024
Physician Perspectives on the Nonclinical Factors That Contribute to Decision-Making for Advanced Prostate Cancer Care: A Qualitative Study.
September 18, 2024
Risk factors for Gleason score upgrade from prostate biopsy to radical prostatectomy.
September 18, 2024
Safety profile of darolutamide versus placebo: a systematic review and meta-analysis.
September 18, 2024
Cancer cell states: Lessons from ten years of single-cell RNA-sequencing of human tumors
September 17, 2024
Adiposity and Muscle Strength in Men With Prostate Cancer and Cardiovascular Outcomes
September 17, 2024
Germline Pathogenic Variants Identified in Patients With Genitourinary Malignancies Undergoing Universal Testing: A Multisite Single-Institution Prospective Study
September 17, 2024
Integrative identification of non-coding regulatory regions driving metastatic prostate cancer.
September 17, 2024
Current uses and resistance mechanisms of enzalutamide in prostate cancer treatment.
September 17, 2024